CMS selects 10 drugs for price negotiation – Healthcare Economist

CMS selects 10 drugs for price negotiation – Healthcare Economist
CMS selects 10 drugs for price negotiation – Healthcare Economist


Here is the CMS Factsheet and news coverage from NY Times.

The companies that make each of these drugs is listed below.

  1. Eliquis – Bristol Myers Squibb and Pfizer
  2. Jardiance- Boehringer Ingelheim and Eli Lilly
  3. Xarelto – Johnson & Johnson
  4. Januvia – Merck
  5. Farxiga – AstraZeneca
  6. Entresto – Novartis
  7. Enbrel – Amgen
  8. Imbruvica,- AbbVie and Johnson & Johnson
  9. Stelara, – Johnson & Johnson
  10. Fiasp and NovoLog – Novo Nordisk





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *